Cookie Policy

We've put some small files called essential cookies on your device to help our site work on your browser.
We also use analytical cookies to help up improve our website by collecting and reporting information on it's usage.

You can read more above this on our Privacy Policy page.

I'm ok with analytical cookies Do not use analytics cookies

Investor Presentation – H.C. Wainwright BIOCONNECT Virtual Conference

7 Jan 2022

Shield Therapeutics plc announces that Greg Madison, Chief Executive Officer of Shield, is scheduled to present virtually at the H.C. Wainwright BIOCONNECT Virtual Conference on 10 January, 2022. Please click here for further information.

Back to news